High-dose Valacyclovir HSV-2 Suppression Results in Greater Reduction in Plasma HIV-1 Levels Compared With Standard Dose Acyclovir Among HIV-1/HSV-2 Coinfected Persons: A Randomized, Crossover Trial-Reference-Cited by-同舟云学术

High-dose Valacyclovir HSV-2 Suppression Results in Greater Reduction in Plasma HIV-1 Levels Compared With Standard Dose Acyclovir Among HIV-1/HSV-2 Coinfected Persons: A Randomized, Crossover Trial

Published:2011-10-12 Issue:12 Volume:204 Page:1912-1917
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Mugwanya Kenneth,Baeten Jared M.,Mugo Nelly R.,Irungu Elizabeth,Ngure Kenneth,Celum Connie

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/204/12/1912/18081753/jir649.pdf

Reference29 articles.

1. Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe;Gwanzura;J Infect Dis,1998

2. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection;Celum;J Infect Dis,2005

3. Association between cervical shedding of herpes simplex virus and HIV-1;McClelland;AIDS,2002

4. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression;Schacker;J Infect Dis,2002

5. Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials;Conant;Int J STD AIDS,2002

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination therapy synergism prediction for virus treatment using machine learning models;PLOS ONE;2024-09-04

2. 20 years of herpes simplex virus type 2 (HSV-2) research in low-income and middle-income countries: systematic evaluation of progress made in addressing WHO priorities for research in HSV-2/HIV interactions, HSV-2 control and mathematical modelling;BMJ Global Health;2024-07

3. Establishing adherence–concentration–efficacy thresholds of TDF–FTC pre-exposure prophylaxis for HIV prevention in African women: a protocol for the Women TDF–FTC Benchmark Study;Frontiers in Reproductive Health;2024-05-27

4. Cervical Cytology and Herpes Simplex Virus Type-2 Serology Among Human Immune Deficiency Virus Infected Women on Highly Active Antiretroviral Therapy in Enugu, Nigeria;Current HIV Research;2022-12

5. Polypharmacology in Clinical Applications: Anti-infection Polypharmacology;Polypharmacology;2022